Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Travel Nurses, Inc. Named Top Travel Nurse Agency
Healthcare & PharmaceuticalAwards

Travel Nurses, Inc. Named Top Travel Nurse Agency

July 11, 2025 11:00 AM

Travel Nurses, Inc. has been named No. 2 on the BluePipes list of the best travel nursing agencies for 2025! This marks the third consecutive year the agency has received this recognition and the fifth time it has made the list since 2017.BluePipes evaluated more than 450 travel healthcare staffing companies and aggregated more than 210,000 reviews from five sources. BluePipes manually pulled reviews from Google, Glassdoor, Indeed, Facebook, and...

Read more
Infinite Auctions Offers LeBron James' 2014 NBA Finals Game-Worn & Signed Jersey - A Monumental Piece of NBA History
Healthcare & PharmaceuticalProduct Announcements

Infinite Auctions Offers LeBron James' 2014 NBA Finals Game-Worn & Signed Jersey - A Monumental Piece of NBA History

July 11, 2025 9:11 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), through its wholly owned subsidiary Infinite Auctions, is thrilled to announce the live online auction of one of the most historically significant NBA jerseys in modern basketball history - LeBron James' game-worn and signed white home jersey from Game 4 of the 2014 NBA Finals, authenticated by MeiGray, Real Game Used, and Upper Deck Authenticated.The auction is now live at www.infiniteauctions.com...

Read more
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
Healthcare & PharmaceuticalCompany Update

MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition

July 11, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) today announced new preclinical results from SKNY-1, an oral drug candidate for obesity and nicotine addiction currently under definitive agreement for acquisition. In a validated behavioral model used to measure Cannabinoid 1 receptor (CB1) related anxiety-like effects, SKNY-1 demonstrated clear reversal of anxiety-related behavior induced by a CB1 activator, setting it apart from earlier CB1-targeting...

Read more
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025
Healthcare & PharmaceuticalEarnings

Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025

July 11, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report its second quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.Webcast: https://investors.modernatx.comThe archived webcast will be available on Moderna's website...

Read more
Encision Reports Fourth Quarter Fiscal Year 2025 Results
Healthcare & PharmaceuticalEarnings

Encision Reports Fourth Quarter Fiscal Year 2025 Results

July 11, 2025 5:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company that owns the patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal year ended March 31, 2025.The Company posted quarterly net revenue of $1.52 million for a quarterly net loss of $47 thousand, or $(0.00) per diluted share. These results compare to net revenue of...

Read more
Interim Report January-June 2025
Healthcare & PharmaceuticalEarnings

Interim Report January-June 2025

July 11, 2025 1:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)A quarter showing a mixed pictureSecond quarter 2025 (Apr-Jun)• Net sales amounted to SEK 178.3 million (210.3), corresponding to negative growth of -15 percent in SEK and -9 percent in local currencies. Organic growth amounted to -11 percent in local currencies.• The business area Abdominal delivered sales growth of 19 percent in local currencies. Thoracic and Services returned negative growth:...

Read more
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair

July 10, 2025 6:00 PM

Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Islam Mohamed as Chair of its Scientific and Clinical Advisory Board. This appointment reflects the Company's commitment to scientific excellence and its mission to accelerate the development of innovative oncology solutions through expert-led translational research.Dr. Islam Mohamed is an experienced...

Read more
CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
Healthcare & PharmaceuticalProduct Announcements

CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs

July 10, 2025 5:00 PM

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgaris,1 is now available to beneficiaries of the public drug plans of Ontario and Nova Scotia as well as through the federal government's Non-Insured Health Benefits (NIHB) drug plan for Indigenous...

Read more
Reporting of Transactions Made by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them in Gubra A/S' Shares
Healthcare & PharmaceuticalRegulatory

Reporting of Transactions Made by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them in Gubra A/S' Shares

July 10, 2025 4:30 PM

Pursuant to the Market Abuse Regulation article 19, Gubra A/S (CPH:GUBRA), CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto.1.Details of the person discharging managerial responsibilities/person closely...

Read more
Bausch Health Appoints New Chief Accounting Officer
Healthcare & PharmaceuticalManagement Changes

Bausch Health Appoints New Chief Accounting Officer

July 10, 2025 4:15 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Steven Lee as Senior Vice President, Controller and Chief Accounting Officer, effective Monday, July 14.Steven brings extensive experience in financial transformation, mergers and acquisitions, and operational execution. With over two decades of experience, Steven has consistently demonstrated his proficiency in...

Read more
Glow Sauna Studios Expands to California, Bringing Infrared & Light Therapies to the Inland Empire
Healthcare & PharmaceuticalCompany Update

Glow Sauna Studios Expands to California, Bringing Infrared & Light Therapies to the Inland Empire

July 10, 2025 1:36 PM

Glow Sauna Studios, a fast-growing wellness brand known for premium full spectrum infrared sauna and red light therapy experiences, is proud to announce its expansion into California, beginning in Chino. This marks a major milestone for the brand as it enters one of the most wellness-driven states in the country. Infrared saunas are celebrated for their numerous health benefits; such as detoxification, improved circulation, skin rejuvenation,...

Read more
Ikaria Lean Belly Juice Reviews & Complaints (2025 Consumer Report) Ingredients, Benefits, and Real Results
Healthcare & PharmaceuticalCompany Update

Ikaria Lean Belly Juice Reviews & Complaints (2025 Consumer Report) Ingredients, Benefits, and Real Results

July 10, 2025 12:15 PM

Inside This Review, You'll Learn:The hidden reason behind persistent belly fat that dieting and working out might not fixWhat sets Ikaria Lean Belly Juice apart from the typical weight loss formulasThe surprising role ceramides play in metabolism, digestion, and fat accumulationA closer look at standout ingredients like Fucoxanthin, Panax Ginseng, EGCG, and othersTangible benefits such as boosted energy, smoother digestion, and fewer cravingsHow...

Read more
GluvaFit Reviews: The Natural Solution to Blood Sugar, Weight & Blood Pressure Problems
Healthcare & PharmaceuticalCompany Update

GluvaFit Reviews: The Natural Solution to Blood Sugar, Weight & Blood Pressure Problems

July 10, 2025 11:45 AM

Balance blood sugar, reduce insulin resistance, and support weight loss with GluvaFit. Safe, natural ingredients. Now shipping across the USA & United Kingdom.If you've been battling high blood sugar levels, waking up in the middle of the night due to heart palpitations, or finding it nearly impossible to lose stubborn weight despite your best efforts-you're not alone. Every day, millions silently struggle with hidden metabolic imbalances that...

Read more
SonoVive Reviews & Complaints 2025: Ingredients, Benefits, and Real User Results (Expert Review)
Healthcare & PharmaceuticalCompany Update

SonoVive Reviews & Complaints 2025: Ingredients, Benefits, and Real User Results (Expert Review)

July 10, 2025 11:45 AM

In this article, you will learn:What SonoVive is and how it aims to support hearing healthThe science behind how it works to target hearing lossKey natural ingredients included in the formula and their benefitsHow to use SonoVive safely and effectivelyThe potential benefits you can expect from regular useReal customer experiences and satisfaction levelsPricing options, purchasing details, and the money-back guaranteeAnswers to common questions...

Read more
Independent Practices Delay Critical Tech Upgrades as Federal EHR Deadlines and Cyber Risks Loom
Healthcare & PharmaceuticalCompany Update

Independent Practices Delay Critical Tech Upgrades as Federal EHR Deadlines and Cyber Risks Loom

July 10, 2025 11:45 AM

As new federal TEFCA and interoperability mandates take effect and healthcare cyberattacks reach record highs in 2025, independent physician practices are facing mounting risks from significant gaps in electronic health record (EHR) readiness, according to a new Black Book Research survey. The findings, based on input from hundreds of independent practices across the U.S., highlight a pattern of technology avoidance that could threaten...

Read more
Independent Physician Practices Struggle for Survival as Value-Based Care Pressures Mount, Black Book Q2 Survey Finds
Healthcare & PharmaceuticalCompany Update

Independent Physician Practices Struggle for Survival as Value-Based Care Pressures Mount, Black Book Q2 Survey Finds

July 10, 2025 11:00 AM

As the U.S. healthcare system accelerates toward value-based care (VBC) models and consolidation surges in 2025, independent physician practices are fighting for survival. New data from a Q2 Black Book Research poll of 496 practices reveals that 70% do not expect to maintain autonomy beyond the next 18 months without major changes to their operational strategies, partnerships, or financial management.The study, conducted from March to June 2025,...

Read more
Conference Call on Interim Report April-June 2025
Healthcare & PharmaceuticalConference Call

Conference Call on Interim Report April-June 2025

July 10, 2025 10:40 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2025. The presentation will be held in English.Time: Tomorrow, Friday July 11 at 2.00 pm CET / 8.00 am ESTIf you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. https://xvivo.events.inderes.com/q2-report-2025If you wish to participate via...

Read more
OTC PINK:MDCE Powers Forward as All Three Business Units Hit Growth Milestones
Healthcare & PharmaceuticalCompany Update

OTC PINK:MDCE Powers Forward as All Three Business Units Hit Growth Milestones

July 10, 2025 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), a diversified holding company focused on AI-powered healthcare innovation, authentication science, and premium collectibles, is pleased to announce explosive operational momentum across all three of its core businesses: Medical Care Technologies, Infinite Auctions, and Real Game Used (RGU).At Medical Care Technologies, the company's health tech division, research and development has reached a...

Read more
Michael Sherman, Former Chief Medical Officer of Point32Health, Joins Real Endpoints as Senior Advisor and Payer Insights Leader
Healthcare & PharmaceuticalCompany Update

Michael Sherman, Former Chief Medical Officer of Point32Health, Joins Real Endpoints as Senior Advisor and Payer Insights Leader

July 10, 2025 9:00 AM

Real Endpoints (RE), a premier market access solutions firm, today announces the appointment of Michael Sherman, MD, MBA, MS, as Senior Advisor and Payer Insights Leader.Dr. Sherman is nationally recognized for his skill and innovation in pharmaceutical and diagnostic contracting, including forging partnerships with manufacturers that generate credible real-world evidence to support payer decision making. With more than 25 years of management...

Read more
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Healthcare & PharmaceuticalCompany Update

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

July 10, 2025 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), under its Jaguar Animal Health tradename for the veterinary market, today announced that four dogs have now been enrolled in Jaguar's ongoing field study of Canalevia-CA1, the company's U.S. Food and Drug Administration (FDA) conditionally approved prescription drug for the treatment of chemotherapy-induced diarrhea (CID) in dogs, and enrollment is continuing. Six veterinary oncology clinics have...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?